Abstract
Meningiomas are the most common primary non-glial intracranial neoplasms. In most cases, meningiomas have typical imaging appearances and locations, enabling a straightforward radiological diagnosis. However, a myriad of unusual appearances potentially complicate the imaging picture. Furthermore, certain imaging features can also predict the specific histopathological nature and WHO grade of the meningioma. ‘Typical’ meningiomas include meningothelial, fibrous, and transitional variants and have the characteristic imaging features described for meningiomas. Several ‘atypical’ variants exist, which, although less common, also generally have a less favourable prognosis and necessitate early diagnosis. In addition, meningiomas can occur in a variety of unusual intracranial and even extra-cranial locations and need to be distinguished from the more common tumours of these regions on imaging. Any associated oedema or haemorrhagic changes may alter the prognosis and have to be carefully assessed and reported. Cystic changes in meningiomas have been divided into five subtypes, and accurate characterisation is essential to predict the prognosis. An extensive review of the several possible variations in imaging appearances of meningiomas including the differential features of common and uncommon variants would facilitate informative radiological reporting of meningiomas. This would be expected to improve pre-operative planning prior to surgical biopsy and thereby improve disease prognosis and patient outcomes.
Keywords: meningioma, typical meningioma, atypical meningioma, cystic meningioma
Introduction
Meningiomas are the most common primary non-glial intracranial neoplasms, constituting about one-third of all central nervous system (CNS) tumours and about 16 to 20% of all intracranial neoplasms [1]. Meningiomas are easily detectable on imaging studies such as computed tomography (CT) and magnetic resonance imaging (MRI). They usually have characteristic imaging appearances and locations, enabling a straightforward radiological diagnosis. However, a myriad of unusual appearances potentially complicate the imaging picture and pose a diagnostic dilemma. Furthermore, subtle features on imaging give clues to predict the specific histopathological nature and World Health Organisation (WHO) grade of the meningioma. This radiological information would be expected to help surgeons improve surgical planning prior to biopsy and thereby improve patient management.
According to recent data from worldwide registries, the annual incidence of meningiomas lies between 1.28 and 7.8 per 100,000 [2]. The prevalence of meningiomas ranges between 50.4 and 70.7 per 100,000 [3]. It shows a significant female preponderance and is predominantly a tumour of old age. Although most meningiomas are histologically benign, the five-year survival rate of meningiomas is less than 70% and further declines with increasing patient age [4]. The long latent period and asymptomatic nature of slow-growing tumours are responsible for significant delays in diagnosis and management of meningiomas.
Intrinsic risk factors for meningioma include age, sex, ethnic group, family history, and genetic polymorphisms. Turner’s syndrome, Werner’s syndrome, neurofibromatosis 2, and familial cancer syndromes involving NF1, PTCH, CREBBP, VHL, PTEN, and CDKN2A genes also predispose for the development of meningioma [5]. Several extrinsic risk factors such as electromagnetic fields, prior head injury, and nutritional, toxic, and hormonal factors have been identified as potential risk factors [6]. Meningiomas are usually asymptomatic. New onset headaches, seizures, focal neurological dysfunction, or cranial nerve palsies are the common presenting complaints in symptomatic cases and justify neuroimaging for diagnosis and further evaluation [7].
WHO classification of meningiomas
The 2016 WHO classification system is based on the pathological evaluation of meningioma tissues. It divides meningiomas into 15 subtypes, which are further categorised into three grades that predict the prognosis of the tumour [8]. Recurrence rate and mortality progressively increase, while successful gross total tumour resection rate and survival rate progressively reduce from WHO grade I to grade III tumours [9]. Subtle differences in imaging characteristics can predict specific histopathological subtypes, thereby enabling pre-operative prediction of the pathological meningioma subtype.
Imaging features of meningioma variants
Over 80% of meningiomas are of the meningothelial, fibrous, or transitional subtypes, with the meningothelial subtype comprising about 58% of cases [10]. These are the so-called ‘typical’ meningiomas. The remaining subtypes are the uncommon ‘atypical’ subtypes.
WHO grade I
Meningothelial variant
This is the most common variant of meningioma, consisting histologically of meningothelial cells, and showing the classical imaging findings described for meningioma. It appears hyperdense on non-enhanced CT (NECT), isointense to hypointense on T1WI, isointense to hyperintense on T2WI, and shows intense homogeneous post-contrast enhancement on both contrast-enhanced CT (CECT) and T1WI contrast-enhanced (T1WI-CE) MRI sequence (Figure 1). It usually shows no diffusion restriction. Hyperostosis of the underlying bone, CSF cleft around the tumour, and an enhancing dural tail are other classical features [11]. Inward buckling of the cortical grey matter is also seen, indicating its extra-axial nature. Intratumoural calcifications may be present. On MR spectroscopy (MRS), alanine peak and glutamine/glutamate peak are seen. Alanine peak is relatively specific for meningiomas [12]. Appearance of the tumour on T2WI is important in differentiating between the three subtypes of ‘typical’ meningiomas.
Fibrous variant
This is the second subtype of ‘typical’ meningioma. The appearance is similar to that of meningothelial meningioma; however, it shows prominent hypointensity on T2WI due to the presence of a fibrous component. Furthermore, the enhancement pattern, although homogeneous, is less intense and relatively delayed as compared to the meningothelial variant (Figure 2).
Transitional variant
The final subtype of ‘typical’ meningiomas, the transitional variant, contains both meningothelial and fibrous components and has a heterogeneous appearance on T2WI and heterogeneous post-contrast enhancement (Figure 3).
Psammomatous variant
This variant is characterised by the presence of psammoma bodies on histology. On imaging, the characteristic feature of this variant is the prominent dense intratumoural calcification, present either diffusely or in the periphery of the meningioma. Spinal meningiomas, particularly those in the thoracic spine, show a propensity to psammomatous histology [13]. The calcification is easily visualised as prominent hyperdense areas on NECT and as prominent areas of signal loss (blooming) on gradient echo (GRE) or susceptibility weighted (SWI) sequences (Figure 4). Strong post-contrast enhancement is seen in the non-calcified parts of the tumour.
Angiomatous variant
This is a rare subtype of meningioma with a male preponderance characterised by a predominance of large blood vessels on histology. Prominent internal and peritumoral flow voids are visible on MRI. An extra-axial space-occupying lesion with large and prominent feeding vessels are appreciable on post-contrast scans. CT angiography (CTA) and MR angiography (MRA) can depict the extensive network of enlarged intratumoural and peritumoural feeding vessels of the tumour (Figure 5). Vivid post-contrast enhancement and disproportionately large peritumoral oedema are other characteristic features of this subtype [14]. Despite the aggressive appearance of this variant, the prognosis is relatively good.
Microcystic variant
This is the rarest histological subtype of meningioma and is characterised by intratumoural microcystic spaces on histology. It has a characteristic hypodense or isodense appearance on NECT, in contrast to the hyperdense appearance of other meningiomas. On MRI, distinctive prominent hypointensity on T1W has been identified as the only significant predictor of microcystic subtype [15]. Post-contrast reticular enhancement is also characteristic of this subtype (Figure 6), although it is only seen in 30% of cases.
Secretory variant
Pseudo-psammoma bodies (intracellular eosinophilic inclusions) characterise this subtype of meningioma on histology. It shows a predilection for skull base location. The distinguishing feature of the secretory variant on imaging is the characteristic intense hyperintensity on T2W, which is seen in up to 96% of cases [16]. In many cases, the intensity of the tumour on T2W nearly parallels that of CSF (Figure 7).
Lymphoplasmacyte-rich variant
This is a rare subtype presenting in relatively young patients with secondary hypergammaglobulinaemia and anaemia. Chronic inflammatory infiltrates characterise the histological picture. On imaging it forms a characteristic en-plaque pattern with irregular margins extending along the dura, which appears isodense to hyperdense on NECT and isointense to hypointense on T1WI. It has variable signal intensity on T2WI. Post-contrast scan shows intense homogeneous enhancement (Figure 8). Another characteristic feature is the presence of diffusion restriction, in contrast to other WHO grade I meningiomas. Underlying brain parenchyma commonly shows oedema and cystic changes [17]. Although the appearance is characteristic in relation to other types of meningiomas, the en-plaque lesion itself potentially has a large spectrum of differentials such as hypertrophic pachymeningitis, histiocytic disorders, tubercular pachymeningitis, connective tissue disorders, neurosarcoidosis, and lymphoma, from which it may sometimes be indistinguishable on the basis of imaging alone.
Metaplastic variants
Histologically, this variant is characterised by the presence of focal or diffuse mesenchymal components, which may be osseous, chondroid, myxoid, lipomatous, or xanthomatous in nature. Imaging features are variable and depend on the mesenchymal component present. Usually specific features of mesenchymal components are superimposed on a background of tumour tissue, with typical imaging characteristics of a meningioma. For instance, xanthomatous meningioma shows diffuse hypodensity on NECT with focal areas of fat attenuation and small fat components on MRI (Figure 9). Lipomatous variant, a close differential on imaging, shows larger areas of intratumoural fat [18].
WHO Grade II
Chordoid variant
This variant shows histological similarity to chordomas with presence of mucoid matrix, which gives specific diffusion characteristics to the tumour. It is associated with Castleman disease in childhood, although this is rare. Its characteristic imaging feature is the presence of high diffusivity with facilitated diffusion, appearing hyperintense on apparent diffusion coefficient (ADC) maps and hypointense on diffusion-weighted (DWI) sequence (Figure 10). It has the highest mean ADC value of all meningiomas (1.62 ± 0.33 × 10−3 mm2/s), the values being almost double that of grade I (0.88 ± 0.13 × 10−3 mm2/s) and non-chordoid grade II (0.84 ± 0.11 × 10−3 mm2/s) meningiomas; grade III meningiomas show diffusion restriction with low mean ADC values (0.57 × 10−3 mm2/s) [19].
Clear cell variant
This subtype is histologically comprised of polygonal cells with clear cytoplasm. It shows a predilection for younger patients and cerebellopontine (CP) angle location (Figure 11). Usually these tumours show a heterogeneous enhancement pattern. Peritumoral oedema and cyst formation in the underlying brain parenchyma is common. Being a WHO grade II tumour, osteolysis of the underlying bones is more common than hyperostosis [20], and hence this feature cannot be used to differentiate CP angle clear cell meningioma from the more common CP angle tumour, acoustic schwannoma. However, certain imaging clues do exist, which can be used to differentiate them (Table 1) [21].
Table 1.
Meningioma | Acoustic schwannoma |
---|---|
Sessile, broad based towards petrous base | Globular |
Usually cause no widening of CP angle | Usually cause widening of CP angle |
Intratumoural calcification more common | Intratumoural calcification less common |
Presence of dural tail | Absence of dural tail |
Usually show intense enhancement | Usually show moderate enhancement |
Atypical variant and WHO grade III meningiomas
Atypical subtype of grade II and all three subtypes of grade III meningiomas can essentially be differentiated only based on histopathology and cannot be definitively differentiated from each other on imaging. However, on the basis of imaging findings, a prediction of high-grade meningioma can be made by the radiologist [22]. They occur in relatively old patients and show a male predominance. Imaging features predicting a high-grade meningioma include an extra-axial mass showing irregular tumour margins with indistinct tumour-brain interfaces, lack of sharply defined enhancement margins, heterogeneous signal intensity and enhancement pattern, eccentric intratumoural necrosis, extensive peritumoral oedema, definite invasion of underlying brain parenchyma, and destruction of the overlying bone (Figure 12). In contrast to grade I and other grade II meningiomas, these show diffusion restriction [23]. On dynamic contrast-enhanced MRI, the volume transfer constant Ktrans shows higher values as compared to other meningiomas. MRS may be necessary for confirmation if conventional imaging findings are not sufficiently diagnostic of meningioma and it shows an alanine peak (specific) and glutamine/glutamate peak in the tumour. Important differentials of high-grade meningiomas include haemangiopericytoma (differentiated from meningioma by the presence of myoinositol peak on MRS) and metastases (usually differentiated from meningioma by the presence of multiple lesions).
The main differentiating features on imaging of the various histopathological subtypes of meningiomas are shown in Table 2.
Table 2.
Pathological subtype | Distinguishing imaging features |
---|---|
Meningothelial | Classical meningioma pattern |
Fibrous | T2W hypointensity |
Transitional | T2W heterogeneous appearance |
Psammomatous | Dense calcification |
Angiomatous | Large, prominent intratumoural and peritumoral feeding vessels |
Microcystic | T1W hypointensity |
Secretory | Skull base location, T2W hyperintensity |
Lymphoplasmacyte-rich | En-plaque pattern |
Metaplastic | Mesenchymal components on background of meningioma |
Chordoid | High mean ADC values |
Clear cell | Cerebellopontine angle location, osteolysis |
Atypical and WHO grade III | Ill-defined margins, diffusion restriction, high Ktrans |
Uncommon locations of meningioma
Common locations of meningiomas include parasagittal region (Figure 13), cerebral convexity (Figure 1), and sphenoid wing (Figure 12), which account for about 70% of meningiomas. Meningiomas can also occur in several uncommon intracranial and extracranial locations and need to be distinguished from the more common tumours of these regions on imaging [11]:
skull base: usually secretory variant (Figure 7); differentials include other skull base mass lesions depending on location, such as chondrosarcoma, chordoma, multiple myeloma, histiocytic disorders, or metastases;
cerebellopontine angle: Usually clear cell variant (Figure 11); differentials include other CP angle masses, especially acoustic schwannoma;
sellar/suprasellar/parasellar meningiomas (Figure 14): Differentials include craniopharyngioma or pituitary tumours;
posterior fossa meningiomas (Figure 15): Differentials include other posterior fossa extra-axial masses such as paragangliomas (particularly the hyperostotic variant) and schwannomas;
tentorial/tentorial apex meningiomas (Figure 16);
intraventricular/choroid plexus meningiomas (Figure 17): differentials include more common intraventricular lesions such as choroid plexus papilloma (differentiated by its lobulated appearance and presence of hydrocephalus), subependymoma (differentiated by its weak post-contrast enhancement);
optic nerve sheath meningioma (Figure 18): differential includes optic nerve glioma, usually differentiated by the visualisation of the optic nerve coursing through the meningioma (‘tram track sign’);
orbital wall meningioma (Figure 19): differentials include other extraconal orbital lesions;
spinal canal meningioma: thoracic spinal canal meningioma is usually of the psammomatous variant (Figures 20 and 21) – differentials include other extramedullary spinal canal lesions;
ectopic meningiomas: These are extremely rare and may involve the head and neck, mediastinum, retroperitoneum, pelvis, or extremities. They probably arise from meningothelial cell rests in these regions. Differentials are extensive, and diagnosis is usually made only on histopathology.
Oedematous brain changes in meningioma
Oedema has been reported to be associated with meningiomas in as many as 60% of cases [24] and is usually vasogenic in nature. Oedema is most frequently associated with microcystic, angiomatous, and lymphoplasmacyte-rich variants. It is least common in the posterior fossa location of meningiomas. There are some imaging findings that predict occurrence of oedema [25]:
pial blood vessels supplying the tumour,
absence of CSF cleft between tumour and brain,
irregular tumour margins,
T2W hyperintensity (higher water content).
Haemorrhagic changes in meningioma
Haemorrhage in meningioma is uncommon. It is more common in the fibrous variant of meningioma. Intraventricular and convexity location of meningiomas show a higher propensity to haemorrhage. It has no association with the angiomatous subtype or the grade of meningioma [26]. Diagnosis is usually straightforward on NECT or GRE/SWI sequences on MRI (Figure 22).
Cystic changes in meningioma
Cystic changes in meningiomas are usually associated with secretory, lymphoplasmacyte-rich, angiomatous, papillary, rhabdoid, and clear cell variants. Location-wise, they are most commonly seen in convexity meningiomas. Cystic changes in meningiomas were initially classified into four types by Nauta et al. [27]. A fifth type was later added by Worthington et al. [28], which was later histologically correlated [29]:
type I: Intratumoural cyst centrally located within the meningioma (Figure 23);
type II: Intratumoural cyst peripherally located within the meningioma surrounded by tumour (Figure 24);
type III: Cyst within brain adjacent to tumour, wall formed by arachnoid (wall does not show enhancement on imaging) (Figure 25);
type IV: Cyst between tumour and adjacent brain (entrapped CSF) (Figure 26);
type V: Cyst wall with nest of tumour cells, wall formed by tumour cells (wall shows enhancement on imaging) (Figure 27).
Type II and Type V cystic change are usually seen in high-grade meningiomas.
Conclusions
An extensive review of the possible variations in the imaging appearance of meningiomas, including the differential features of the common and uncommon variants, would enable radiologists to not only provide accurate diagnosis but also predict their histopathological nature and WHO grade. This would be expected to improve pre-operative planning prior to surgical biopsy and thereby improve disease prognosis and patient outcomes.
Disclosure
The authors declare no conflicts of interest.
References
- 1.Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29:197–205. doi: 10.1007/BF00165649. [DOI] [PubMed] [Google Scholar]
- 2.Baldi I, Engelhardt J, Bonnet C, et al. Epidemiology of meningiomas. Neurochirurgie. 2018;64:5–14. doi: 10.1016/j.neuchi.2014.05.006. [DOI] [PubMed] [Google Scholar]
- 3.Porter KR, McCarthy BJ, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol. 2010;12:520–527. doi: 10.1093/neuonc/nop066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.McCarthy BJ, Davis FG, Freels S, et al. Factors associated with survival in patients with meningioma. J Neurosurg. 1998;88:831–839. doi: 10.3171/jns.1998.88.5.0831. [DOI] [PubMed] [Google Scholar]
- 5.Simon M, Bostrom JP, Hartmann C. Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery. 2007;60:787–798. doi: 10.1227/01.NEU.0000255421.78431.AE. [DOI] [PubMed] [Google Scholar]
- 6.Umansky F, Shoshan Y, Rosenthal G, et al. Radiation-induced meningioma. Neurosurg Focus. 2008;24:E7. doi: 10.3171/FOC/2008/24/5/E7. [DOI] [PubMed] [Google Scholar]
- 7.Yamamoto J, Takahashi M, Idei M, et al. Clinical features and surgical management of intracranial meningiomas in the elderly. Oncol Lett. 2017;14:909–917. doi: 10.3892/ol.2017.6174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Harter PN, Braun Y, Plate KH. Classification of meningiomas – advances and controversies. Chin Clin Oncol. 2017;6(Suppl 1):S2. doi: 10.21037/cco.2017.05.02. [DOI] [PubMed] [Google Scholar]
- 9.Ko KW, Nam DH, Kong DS, et al. Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci J Neurosurg Soc Australas. 2007;14:747–753. doi: 10.1016/j.jocn.2006.05.005. [DOI] [PubMed] [Google Scholar]
- 10.Bhat AR, Wani MA, Kirmani AR, Ramzan AU. Histological subtypes and anatomical location correlated in meningeal brain tumors (meningiomas) J Neurosci Rural Pract. 2014;5:244–249. doi: 10.4103/0976-3147.133568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Buetow MP, Buetow PC, Smirniotopoulos JG. Typical, atypical, and misleading features in meningioma. Radiographics. 1991;11:1087–1106. doi: 10.1148/radiographics.11.6.1749851. [DOI] [PubMed] [Google Scholar]
- 12.Yue Q, Isobe T, Shibata Y, et al. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma. Eur Radiol. 2008;18:2901–2911. doi: 10.1007/s00330-008-1079-6. [DOI] [PubMed] [Google Scholar]
- 13.Lee JW, Lee IS, Choi KU, et al. CT and MRI findings of calcified spinal meningiomas: correlation with pathological findings. Skelet Radiol. 2010;39:345–352. doi: 10.1007/s00256-009-0771-1. [DOI] [PubMed] [Google Scholar]
- 14.Liu Z, Wang C, Wang H, et al. Clinical characteristics and treatment of angiomatous meningiomas: a report of 27 cases. Int J Clin Exp Pathol. 2013;6:695–702. [PMC free article] [PubMed] [Google Scholar]
- 15.Chen CJ, Tseng YC, Hsu HL, Jung SM. Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images. J Comput Assist Tomogr. 2008;32:130–134. doi: 10.1097/RCT.0b013e318064f127. [DOI] [PubMed] [Google Scholar]
- 16.Wang DJ, Xie Q, Gong Y, et al. Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution. Int J Clin Exp Pathol. 2013;6:358–374. [PMC free article] [PubMed] [Google Scholar]
- 17.Yongjun L, Xin L, Qiu S, Jun-Lin Z. Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. J Craniofac Surg. 2015;26:132–137. doi: 10.1097/SCS.0000000000001193. [DOI] [PubMed] [Google Scholar]
- 18.Ishida M, Fukami T, Nitta N, et al. Xanthomatous meningioma: a case report with review of the literature. Int J Clin Exp Pathol. 2014;6:2242–2246. [PMC free article] [PubMed] [Google Scholar]
- 19.Pond JB, Morgan TG, Hatanpaa KJ, et al. Chordoid meningioma: Differentiating a rare World Health Organization grade II tumor from other meningioma histologic subtypes using MRI. AJNR Am J Neuroradiol. 2015;36:1253–1258. doi: 10.3174/ajnr.A4309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wang XQ, Huang MZ, Zhang H, et al. Clear cell meningioma: clinical features, CT, and MR imaging findings in 23 patients. J Comput Assist Tomogr. 2014;38:200–208. doi: 10.1097/RCT.0000000000000018. [DOI] [PubMed] [Google Scholar]
- 21.Lalwani AK, Jackler RK. Preoperative differentiation between meningioma of the cerebellopontine angle and acoustic neuroma using MRI. Otolaryngol Head Neck Surg. 1993;109:88–95. doi: 10.1177/019459989310900116. [DOI] [PubMed] [Google Scholar]
- 22.Kawahara Y, Nakada M, Hayashi Y, et al. Prediction of high-grade meningioma by preoperative MRI assessment. J Neurooncol. 2012;108:147–152. doi: 10.1007/s11060-012-0809-4. [DOI] [PubMed] [Google Scholar]
- 23.Hakyemez B, Yildirim N, Gokalp G, et al. The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas. Neuroradiology. 2006;48:513–520. doi: 10.1007/s00234-006-0094-z. [DOI] [PubMed] [Google Scholar]
- 24.Bitzer M, Opitz H, Popp J, et al. Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 1998;140:333–340. doi: 10.1007/s007010050106. [DOI] [PubMed] [Google Scholar]
- 25.Nakano T, Asano K, Miura H, et al. Meningiomas with brain edema: radiological characteristics on MRI and review of the literature. Clin Imaging. 2002;26:243–249. doi: 10.1016/s0899-7071(02)00433-3. [DOI] [PubMed] [Google Scholar]
- 26.Bosnjak R, Derham C, Popović M, Ravnik J. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J Neurosurg. 2005;103:473–484. doi: 10.3171/jns.2005.103.3.0473. [DOI] [PubMed] [Google Scholar]
- 27.Nauta HJW, Tucker WS, Horsey WJ, et al. Xanthochromic cysts associated with meningioma. J Neurol Neurosurg Psychiatry. 1979;42:529–535. doi: 10.1136/jnnp.42.6.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Worthington C, Caron JL, Melanson D, Leblanc R. Meningioma cysts. Neurology. 1985;35:1720–1724. doi: 10.1212/wnl.35.12.1720. [DOI] [PubMed] [Google Scholar]
- 29.Go KO, Lee K, Heo W, et al. Cystic meningiomas: correlation between radiologic and histopathologic features. Brain Tumor Res Treat. 2018;6:13–21. doi: 10.14791/btrt.2018.6.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]